جست‌وجوی استاد و پژوهشگر

Harald Schermمشاهده پروفایل

استاد

• Plant Disease Epidemiology
• Pathogen Biology
• Disease Management in Fruit Crops
• +۱ مورد دیگر

Harald Scherm is a Professor of Plant Pathology at the University of Georgia's College of Agricultural & Environmental Sciences. His research focuses on plant disease epidemiology, particularly pathogen biology and management of diseases in fruit crops, with a 20+ year history at UGA. As Academic Department Head, he emphasizes strengthening integrated research, extension, and instruction while fostering graduates with translational skills for future challenges in plant pathology. Education Ph.D. in Plant Pathology, University of California, Davis (1994) Dipl. Ing. agr. in Agricultural Sciences, Technical University of Munich, Germany (1990) His current efforts include returning to foundational plant disease epidemiology after administrative commitments, welcoming graduate students interested in this area. He also coordinates UGA's interdisciplinary graduate certificate in Agricultural Data Science . Research themes emphasize fungal diseases (e.g., Exobasidium leaf spot, grape downy mildew), disease management in blueberry and blackberry systems, and innovative detection methods like gas sensor arrays and biofilm analysis. Article trends reveal expertise in botanical epidemiology (fungal reproduction cycles, pathogen localization), food safety (harvester hygiene, postharvest decay), molecular diagnostics (Xylella fastidiosa detection, VOC analysis), and agricultural technology (science mapping, electronic cold-pasteurization). Publications span from theoretical plant pathology reviews to applied mechanical harvester sanitation studies. Contact: scherm@uga.edu | Phone: 706-542-2571 | Mailing Address: 2311 Miller Plant Science Buildings, Athens, GA 30602-7274

• Immunology
• Virology
• Vaccine Development
• +۴ مورد دیگر

Ditte Rahbæk Boilesen serves as a Guest Researcher at the University of Copenhagen's Faculty of Health and Medical Sciences within the Department of Biomedical Sciences, specifically focusing on Endocrinology and Metabolism research. Her institutional affiliation places her within Denmark's premier medical research environment at Blegdamsvej 3B in Copenhagen. Her research interests center on viral immunology with particular emphasis on papillomavirus pathogenesis and vaccine development. She investigates T-cell responses to viral infections, novel antigen design for therapeutic vaccines, and mechanisms of immune evasion by oncogenic viruses. Her work bridges fundamental immunological principles with translational applications in cancer immunotherapy, especially for HPV-related malignancies. Analysis of her publication record from 2019-2024 reveals a strong focus on papillomavirus research, particularly HPV vaccine development using various viral vector platforms. Her work demonstrates expertise in both basic virology techniques and preclinical therapeutic development, with several studies progressing from in vitro validation to animal models. The consistent collaboration with Principal Investigator P.J. Holst across multiple publications indicates a stable research environment focused on viral immunology. Dr. Boilesen's research has garnered attention across multiple platforms, with her work being shared by X users and attracting readership on academic platforms like Mendeley. Some of her research has been referenced in patent applications, indicating potential translational impact of her work in vaccine development.

• Clinical Immunology
• Infectious Disease Epidemiology
• Transfusion Medicine
• +۳ مورد دیگر

Lene Holm Harritshøj serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen, affiliated with the Capital Region of Denmark (Region Hovedstaden). Her work bridges clinical immunology and public health research, with primary appointments at Blegdamsvej 9 (2100 Copenhagen Ø) and Blegdamsvej 3 (2200 Copenhagen N). Her research focuses on Clinical Immunology , Infectious Disease Epidemiology , and Transfusion Medicine , with particular expertise in vector-borne diseases (Borrelia, tick-borne encephalitis), blood safety, and SARS-CoV-2 serology. Recent work examines risk factors in immunocompromised populations, PrEP effectiveness, and tissue banking. Analysis of her 21 publications (2022-2025) reveals strong emphasis on public health surveillance (12 studies), blood donor safety (8 studies), and emerging pathogen characterization (5 studies). Her work frequently employs large-scale cohort designs with multi-institutional collaborations across Danish healthcare facilities. Her research has garnered significant attention including: Pickup by 10+ news outlets Reference in policy documents Substantial social media engagement (8+ X users) 23+ Mendeley readers per major publication She actively collaborates with major Danish research groups including the Danish Blood Donor Study and Capital Region infectious disease networks. Her work demonstrates consistent funding support for large-scale epidemiological studies across multiple disease areas.

• Bacteriophage
• Phage-Host Interactions
• Microbiome
• +۴ مورد دیگر

Rodrigo Ibarra Chavez serves as Assistant Professor in the Department of Biology, Microbiology at the University of Copenhagen's Faculty of Science, with a secondary appointment as Guest Researcher in the Section for Hologenomics at the Globe Institute. His research bridges biomedical engineering and microbiology, focusing on bacteriophage-host interactions and microbiome dynamics. His work centers on phage-inducible chromosomal islands (PICIs), synthetic biology applications, and bacterial pathogenesis. Key research areas include developing PICIs as diagnostic platforms, studying phage satellites for biotechnology, and investigating CRISPR-Cas systems for antimicrobial development. His publications reveal strong emphasis on horizontal gene transfer mechanisms, bacterial evolution, and novel antimicrobial strategies. Recent publications show increasing translational focus, with 2023-2024 work advancing diagnostic applications and single-cell analysis of bacterial populations. His research demonstrates significant interdisciplinary collaboration across virology, genetics, and synthetic biology. Dr. Ibarra Chavez maintains active research networks with high citation impact, evidenced by patent references and Wikipedia citations. His work has been highlighted by news outlets and policy sources, indicating real-world scientific influence. He advises no formal students listed in current records but collaborates extensively with international researchers including Penadés, Haag, and Seed. His lab work focuses on phage-based systems and bacterial genome engineering, though specific facility details aren't provided in source materials.

David McNallyمشاهده پروفایل

استادیار

• Viral Vector Manufacturing
• Analytical Methods for Viral Vectors
• Biomanufacturing
• +۳ مورد دیگر

David McNally serves as Assistant Research Professor in the Department of Chemical Engineering at the Francis College of Engineering, University of Massachusetts Lowell, and concurrently as Head of Process Development at MassBiologics' Vector Manufacturing Center in Fall River since 2019, managing a team of 14 researchers across direct and indirect reporting lines. His academic foundation includes a Ph.D. in Chemical Engineering from the University of Cambridge (2013) with thesis research on membrane chromatography for viral vector manufacture under Professor Nigel Slater, and a First-Class BSc in Biomedical Science from the University of Sheffield (2007). Dr. McNally's research pioneers intensified viral vector production platforms and novel analytical characterization methods, driving innovation through industrial-academic partnerships coordinated via the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC). His work specifically targets process efficiency gains for gene therapy vectors and viral vaccines using continuous manufacturing and advanced chromatography techniques. His publication record (2010-2014) reveals consistent focus on chromatographic purification breakthroughs, particularly membrane-based systems for retrovirus and lentivirus processing, establishing foundational methodologies now critical to scalable gene therapy manufacturing. He has secured $2.3 million in competitive research funding as Principal Investigator, including a $1.56M NIST grant for lentiviral vector biomanufacturing intensification and a $760k project developing continuous cell culture models for viral vaccine production. At MassBiologics' Vector Manufacturing Center, he directs process development for clinical-grade viral vectors while advancing AMBIC's mission to transform mammalian biomanufacturing through cross-institutional collaboration and technology transfer.

Teruna Siahaanمشاهده پروفایل

استاد

• Cell Adhesion Molecules
• Targeted Drug Delivery
• Tissue Engineering
• +۳ مورد دیگر

Teruna Siahaan, Ph.D. is the Aya and Takeru Higuchi Distinguished Professor in Pharmaceutical Chemistry at the University of Kansas . He serves as Associate Chair in Pharmaceutical Chemistry and Co-Director of the NIH Biotechnology Training Program. His research centers on leveraging cell adhesion molecules for targeted drug delivery and tissue engineering applications, with strong associations to KU's Bioimaging and Biomolecular Engineering tracks. Recent work focuses on blood-brain barrier modulation using cadherin-derived peptides , enabling enhanced delivery of therapeutics for neurodegenerative diseases and brain tumors . His team develops bioactive peptides for autoimmune disease suppression , antimicrobial therapies , and macromolecule transport across biological barriers. Collaborations span nanotechnology , molecular dynamics simulations , and clinical translation of novel drug delivery systems. The research portfolio demonstrates expertise in peptide engineering translational neuroscience biopharmaceutical development autoimmune disease modulation structural-activity relationship studies in vivo efficacy testing His work combines computational methods with experimental validation to optimize therapeutic candidates for complex diseases.

Richard Louis Hurwitzمشاهده پروفایل

دانشیار

• Gene Therapy
• Retinoblastoma
• Retinal Degeneration
• +۴ مورد دیگر

Dr. Richard Louis Hurwitz is an Associate Professor in the Department of Pediatrics - Oncology at Baylor College of Medicine , Houston, Texas. He is also a member of the Dan L Duncan Comprehensive Cancer Center . Education: BS, Rensselaer Polytechnic Institute (1975) MD, Albany Medical College (1975) Residency, University of Minnesota Affiliate Hospitals Pediatric Hematology-Oncology Fellowship, University of Washington Dr. Hurwitz’s research focuses on gene therapy , retinoblastoma (pediatric retinal cancer), and retinal degeneration . His work explores adenoviral vector delivery, tumor biology, and oncolytic virotherapy. The publications highlight expertise in retinoblastoma models, CD44 receptor interactions, and immune responses to ocular gene delivery. Publications demonstrate a long-term commitment to understanding retinal tumor biology and developing targeted therapies. Key themes include adenoviral vector engineering, tumor-initiating cells, and oncolytic viral treatments for retinoblastoma and medulloblastoma.

Matthew W. VanBrocklinمشاهده پروفایل

دانشیار

• Oncolytic Virotherapy
• Immune Checkpoint Ligands
• CRISPR/HDR Technology
• +۵ مورد دیگر

Matthew W. VanBrocklin is an Associate Professor in the Department of Surgery at the University of Utah , serving as an Investigator at the Huntsman Cancer Institute and member of both the Cell Response and Regulation Program and Melanoma Disease Center . His research program focuses on three key areas: oncolytic virotherapy , immune checkpoint ligand investigation , and single vector CRISPR/HDR technology . Department of Surgery (General Surgery) Oncological Sciences (Adjunct) VanBrocklin's lab develops oncolytic Picornaviruses that exploit tumor cell vulnerabilities through innate immune pathway loss. His team investigates B7-H3 (CD276) as an emerging immunotherapeutic target, aiming to identify its receptor and develop blocking antibodies. The CRISPR/HDR platform achieves 23% repair efficiency in vitro, with ongoing in vivo evaluations for genetic disorders like cystic fibrosis and muscular dystrophy. Recent publications highlight his work on: miR211-5p transdermal delivery for BRAFV600E+ nevi stabilization (2025) AKT/mTOR pathway suppression in melanoma (2024) BRAFV600E microRNA mechanisms (2021) Aspirin's protective effects against UVB damage (2020)

Suvi Kuivanenمشاهده پروفایل

پژوهشگر ارشد

• Biomedicine
• Virology
• Infectious Diseases
• +۴ مورد دیگر

Suvi Kuivanen is an Academy Research Fellow at the University of Helsinki , affiliated with the Faculty of Biological and Environmental Sciences and the Molecular and Integrative Biosciences Research Programme . Her research focuses on Biomedicine , with expertise in Virology , Infectious Diseases , and Public Health . Email: suvi.kuivanen@helsinki.fi Address: P.O 56 (Viikinkaari 9), 00014 University of Helsinki Research Interests include: Viral-host interactions in pathogens like SARS-CoV-2 and tick-borne encephalitis virus Antiviral drug development through computational and experimental approaches Neurovirology examining viral impacts on olfactory and central nervous systems Immunology of mucosal-associated invariant T cells and granulocyte responses in infections Recent publications analyze SARS-CoV-2 infection mechanisms , urban pollution effects on viral susceptibility , and zoonotic potential of henipaviruses . Her work combines molecular biology , structural analysis , and public health strategies . Scientific Awards : Academy Research Fellow (Academy of Finland, 2024–2029) Active research projects include 'Uncovering the zoonotic potential of henipaviruses in European shrews', funded by the Research Council of Finland.

Steven Skienaمشاهده پروفایل

استاد آموزشی

• Data science
• Natural language processing
• Algorithms
• +۴ مورد دیگر

Steven Skiena is a Teaching Professor in the Department of Computer Science at Stony Brook University , where he serves as Director of the Institute for AI-Driven Discovery and Innovation. He is also a co-founder and Chief Scientist at General Sentiment, a media measurement company. PhD in Computer Science from the University of Illinois in 1988. Skiena’s research focuses on the design of graph, string, and geometric algorithms with applications in biology, large-scale text analytics, and sentiment analysis. His work bridges machine learning and AI with diverse domains including social media, linguistics, and healthcare. His most recent publications highlight advancements in natural language processing , graph algorithms , vaccine development , and computational social science . Topics span identity analysis, network embeddings, and audio-based aging research. Scientific Awards : Fulbright Scholar, ONR Young Investigator Award, Chancellor's Award for Teaching, IEEE Computer Science and Engineering Teaching Award. Skiena advises graduate research projects and teaches courses such as CSE 101 , CSE 373 , and CSE 691 . He leads the Data Science Laboratory , which develops tools for text and network analysis.

Laura Palagiمشاهده پروفایل

استاد

• Nonlinear Optimization
• Mixed Integer Nonlinear Programming
• Semidefinite Programming
• +۷ مورد دیگر

Laura Palagi is a Full Professor at Sapienza University of Rome, Department of Computer, Automation, and Management Engineering "Antonio Ruberti". She has been with the institution since 1996, progressing from Researcher to Associate Professor in 2005, and Full Professor since March 2020. She currently serves as Coordinator of the PhD program in Automatic Control, Bioengineering and Operations Research (ABRO) since February 2024 and is the GEP committee representative at the DIAG Department. Her research focuses on developing and analyzing methods for solving nonlinear optimization problems with continuous and discrete variables. Key research themes include decomposition methods for training Support Vector Machines and Deep Networks, methods for Mixed Integer Nonlinear Programming (MINLP), Semidefinite Programming (SDP), standard quadratic problems (StQP), and convex quadratic constrained problems. She also develops predictive machine learning models for healthcare applications and surrogate models for engineering. Her recent publications span optimization methods, machine learning applications in healthcare, sustainability assessment, and network design. Her work demonstrates a strong integration of theoretical optimization with practical applications across multiple domains. Continuous Optimization Awards 2020 Member Best Paper Award from Journal of Global Optimization Honorable Mention from Marguerite Frank Award jury for Best EJCO Paper 2024 EURO Doctoral Dissertation Award Professor Palagi teaches multiple courses including Optimization and Decision Science, Laboratory of Decision Science, Optimization Methods for Machine Learning, and Optimization for Medical programs. She serves as thesis advisor for numerous Bachelor's and Master's students in Management Engineering, Mechanical Engineering, and Data Science programs.

Marie-Noëlle Giraudمشاهده پروفایل

مدرس پاره‌وقت

• Cardiovascular Regeneration
• Biomaterials
• Myocardial Repair
• +۳ مورد دیگر

Dr. Marie-Noëlle Giraud is a part-time lecturer and senior assistant at the Department of Medicine, University of Fribourg, specializing in cardiovascular regeneration and tissue engineering. She leads the Heart Repair & Regeneration Laboratory and investigates cell-biomaterial interactions, paracrine effects of engineered tissues, and inflammation's role in cardiac repair through animal models. Focus on myocardial and vessel regeneration using cell-based therapies and biomaterials Develops biological bandages containing cells and matrices for cardiac repair Studies macrophage polarization in cardiac repair mechanisms Investigates endurance training's impact on post-MI recovery Researches bioresorbable polymeric stents for coronary artery disease Her recent publications emphasize vascular injury models, bioreactor systems, and biomaterial development for cardiovascular applications. The laboratory employs advanced techniques in 3D cell culture, echocardiography, and histological analysis.

• Crystallography
• X-ray Diffraction
• Materials Physics
• +۷ مورد دیگر

Helge Bøvik Larsen is a Professor of Physics at the University of Stavanger, affiliated with the Faculty of Science and Technology and the Department of Mathematics and Physics. His research focuses on crystallography, X-ray diffraction, and materials physics, particularly in alloy systems and diffraction theory. Research Interests: Crystallography and structural analysis of embedded phases in metallic alloys Theoretical and experimental X-ray diffraction, including three-beam and resonant diffraction Development of computational tools for crystallographic modeling using Mathematica Synchrotron-based studies of Al-Zn-Mg and Al-Mg-Zn systems Angle calculations and instrumentation for diffractometers (kappa and goniostat systems) Applications in materials science, including cementitious binders and gene transfer lipids The recent publications highlight a strong trend in both fundamental diffraction physics and applied materials characterization. His work bridges theoretical crystallography with experimental validation, often using synchrotron radiation. There is also interdisciplinary work in biophysics (cationic lipids for gene therapy) and sustainable materials (geopolymers from mine waste), indicating collaborative and cross-cutting research. Scientific Contributions: Extensive contributions to three-beam X-ray diffraction theory and extinction effects Development of software and Mathematica-based tools for diffraction simulations Studies on goniostat and diffractometer geometry for precise crystal alignment Structural analysis of complex systems like α-D-glucose-NaCl-H₂O and silver sulfate Advising and Grants: While no explicit list of students or grants is provided, his long publication record with junior co-authors (e.g., Ramsnes, Zhang, Jubeli) suggests active supervision and mentorship. His collaborations with industry and international facilities (e.g., ESRF) indicate participation in funded research projects. The repeated co-authorship with Gunnar Thorkildsen and Ragnvald Mathiesen reflects sustained research teams and likely grant-supported work. Labs and Teams: His work implies involvement with X-ray diffraction laboratories, likely including access to synchrotron facilities. He has been part of a long-standing research group at the University of Stavanger focused on crystallography and materials characterization, often collaborating with physicists, chemists, and engineers.

James M. Riniمشاهده پروفایل

استاد

• Structural Biology
• Glycobiology
• Molecular Immunology
• +۳ مورد دیگر

Dr. James M. Rini is a Professor in the Department of Biochemistry at the University of Toronto. His research focuses on structural biology, glycobiology, and virology, with particular emphasis on protein-carbohydrate interactions, glycosyltransferase mechanisms, coronavirus receptor binding, and therapeutic antibody engineering. Education: Ph.D. in Medical Biophysics, University of Toronto Postdoctoral Training: Research Institute of Scripps Clinic Research in the Rini lab spans three major areas: (1) Elucidating how glycosyltransferases like UGGT, POFUT1, and POFUT2 regulate ER quality control and Notch receptor trafficking. (2) Investigating structural determinants of coronavirus S-protein interactions with host receptors to understand immune evasion and viral evolution. (3) Engineering therapeutic antibodies by modifying N-glycans at Asn-297 to enhance clinical efficacy for cancer and arthritis treatment. His work integrates x-ray crystallography with cell-based assays and chemoenzymatic approaches. Key publications include structural studies on SARS-CoV-2 neutralizing antibodies, Notch glycosylation, and mammalian cell expression systems. Current projects involve understanding proteostasis mechanisms and developing virus-like particle assays.

David Safronetzمشاهده پروفایل

استاد مدعو

• Virology
• Infectious Diseases
• Zoonotic Viruses
• +۳ مورد دیگر

Dr. David Safronetz is a principal investigator at the Public Health Agency of Canada's National Microbiology Laboratory and an adjunct professor at the University of Manitoba's Max Rady College of Medicine. His research program focuses on highly pathogenic zoonotic viruses, including hantaviruses, Lassa virus, Lujo virus, and Crimean-Congo hemorrhagic fever virus. University of Manitoba, PhD (Medical Microbiology & Infectious Diseases) University of Manitoba, MSc (Medical Microbiology & Infectious Diseases) University of Saskatchewan, BSc (Medical Microbiology & Immunology) Dr. Safronetz's research involves developing and characterizing in vitro and in vivo disease models to understand viral pathogenesis and evaluate medical countermeasures. Notable achievements include creation of a non-human primate model for hantavirus pulmonary syndrome and advancement of a Lassa fever vaccine candidate through pre-clinical trials. His publications from 2015-2025 demonstrate sustained expertise in hemorrhagic fever virology, with recent focus on antiviral therapies (cidofovir/brincidofovir efficacy against Monkeypox) and mucosal immunity mechanisms in influenza. Articles span disease modeling, immunobiology, and public health interventions. 2015 NIH Director’s Award 2014 NIAID Merit Award 2013 NIH Performance Award 2011-2012 NIH Fellows Association Research Excellence Award 2008-2012 NIH Visiting Fellowship Dr. Safronetz currently does not accept graduate students but collaborates extensively with international research teams across virology, immunology, and public health domains. His work receives funding from multiple NIH and Canadian health agencies.